Quince Therapeutics, Inc. (QNCX) › Total LiabilitiesQuince Therapeutics, Inc. (QNCX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2018: $1.46M2019: $8.89M2020: $17.20M2021: $14.64M2022: $3.32M2023: $82.82M2024: $84.33M2025: $129.24M$129.24M2018Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$129.24M+53.2%2024$84.33M+1.8%2023$82.82M+2396.7%2022$3.32M-77.3%2021$14.64M-14.9%2020$17.20M+93.5%2019$8.89M+510.3%2018$1.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share